FFC
ALXN

First Financial Corp’s Alexion Pharmaceuticals ALXN Stock Holding History

First Financial Corp’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-200
Closed -$28K – 475
2016
Q1 		$28K Sell
200
-45
-18% -$6.61K 0.01% 306
2015
Q4 		$47K Hold
245
– – 0.02% 263
2015
Q3 		$38K Hold
245
– – 0.02% 279
2015
Q2 		$44K Hold
245
– – 0.02% 276
2015
Q1 		$42K Sell
245
-15
-6% -$2.71K 0.02% 277
2014
Q4 		$48K Hold
260
– – 0.02% 265
2014
Q3 		$43K Hold
260
– – 0.02% 281
2014
Q2 		$41K Hold
260
– – 0.02% 286
2014
Q1 		$40K Sell
260
-225
-46% -$35.8K 0.02% 288
2013
Q4 		$64K Hold
485
– – 0.03% 237
2013
Q3 		$56K Sell
485
-35
-7% -$3.84K 0.03% 248
2013
Q2 		$48K Buy
+520
New +$50.1K 0.02% 250

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return